Surgeons succeed in removing benign tumour on vestibular nerve that causes deafness

A vestibular schwannoma is a benign tumour consisting of connective tissue and nerve tissue. It is still not known what causes it. 1 - 2 people in every 100,000 develop this type of tumour, which usually presses on the vestibular nerve and at the same time damages the auditory nerve. Up until now it has not been possible to remove the tumour and simultaneously restore the patient's hearing. This is exactly what Christoph Arnoldner of the Department of Ear, Nose and Throat Diseases at MedUni Vienna/Vienna General Hospital and Christian Matula (Department of Neurosurgery at MedUni Vienna/Vienna General Hospital) have now succeeded in doing for the very first time in Austria. This operation is also very rare worldwide.

"In an operation lasting approximately nine hours, we managed to remove the benign tumour on the vestibular nerve, which had caused deafness in the patient," explains Arnoldner. "And, by using a special access and measuring the function on the auditory nerve during the operation, we were also able to insert a cochlear implant during the same operation. So the patient is not only cured from the tumour but has also got her hearing back." The patient is a 45-year-old elementary school teacher from the USA. As soon as the implant was activated one month after the operation, she was able to hear. Further training will enable her to hear even better in future.

This has been made possible by new microsurgical and technical developments, which, amongst other things, allow more conservative surgery, and also by the excellent international position of the surgeons from MedUni Vienna/Vienna General Hospital when it comes to this type of operation. "We are not just playing in the Champions League, we are world leaders," says Matula, adding: "Our expertise and experience and the perfect combination of teamwork between neurosurgery and ENT, together with the new technologies, mark the start of a new chapter for us in this type of operation."

One of the most important elements in this is the ability to measure and display the function of the auditory nerve and its "transmission of stimuli" to the brainstem during the operation. This is done using a measuring device developed by the company MED-EL. This involves using E-BERA (brainstem evoked response audiometry) to stimulate the cochlea with an electrical signal.

ENT Department with an excellent reputation

This latest success underscores the leading position of MedUni Vienna and Vienna General Hospital in the field of ENT implants. The first cochlear implant that was inserted in the Vienna ENT Department in 1977 was also the first multichannel cochlear implant in the world.  September 2011 also saw another world first: for the first time ever, the General Hospital implanted an extremely thin, so-called "floating electrode" as part of a cochlear implant, in order to preserve residual hearing. For this purpose, the MedUni Vienna researchers developed a new, gentle surgical technique and played a significant role in developing the thin electrode, which is only 0.2 mm thick, rather than the previous 0.5 mm.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
New blood biomarkers can help quantify the brain impact of neurosurgery